Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 8:37 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 385–408 of 565 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: CT Scans Clear all

Conditions: Intraductal Papillary Mucinous Neoplasm
Interventions: PET-CT; Procedure
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Acute Coronary Syndromes, Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Colonic Polyps
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 40 Years to 99 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: Scottsdale, Arizona • Rochester, Minnesota

Conditions: Prostate Neoplasm
Interventions: F-18 NaF; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older · Male only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Metastatic Castration-resistant Prostate Cancer
Interventions: Acapatamab, Enzalutamide, Abiraterone, AMG 404; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 99 Years · Male only
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 7
States / cities: Birmingham, Alabama • Orange, California • San Francisco, California + 4 more

Conditions: Renal Cancer
Interventions: 124IcG250; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Dental Implant, Maxillary Sinus Floor Augmentation
Interventions: Low volume CBCT; Procedure
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 85 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Atherosclerosis, Chronic Granulomatous Disease (CGD)
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 156 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Acute Coronary Syndrome, Myocardial Infarction, Unstable Angina Pectoris
Interventions: Cardiac Computed Tomography; Radiation
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 368 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: High Risk of Developing Lung Cancer
Interventions: CT scan & Early CDT Lung test, CT scan & Early CDT Lung test; Radiation · Other
Lead sponsor: National Jewish Health; Other
Eligibility: 50 Years to 75 Years
Enrollment: 1,361 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Diseases of Liver, Colon Carcinoma, Colorectal Carcinoma, Liver Metastases
Interventions: Computed Tomography Scan - 50% Dose Reduction, Computed Tomography Scan - 70% Dose Reduction, Deep Learning Image Reconstruction (DLIR); Diagnostic Test
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 90 Years
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Parkinson Disease
Interventions: Safinamide; Drug
Lead sponsor: Newron Pharmaceuticals SPA; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Conditions Requiring a Brain Magnetic Resonance Imaging, Head Computerized Tomography, or Head Ultrasound
Interventions: Hyperfine MRI; Diagnostic Test
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 0 Days to 22 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Breast Cancer
Interventions: Koning Breast CT; Device
Lead sponsor: Koning Corporation; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Lymphoma
Interventions: Fludeoxyglucose F18, Computed Tomography, Positron emission tomography; Radiation · Procedure
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cirrhosis, End Stage Liver Disease, Hepatitis C
Interventions: Screening; Procedure
Lead sponsor: Minneapolis Veterans Affairs Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2021
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Kidney or Liver Tumors
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Radiation Safety
Interventions: Radiation Alert, Control; Other
Lead sponsor: Montefiore Medical Center; Other
Eligibility: Not listed
Enrollment: 15,969 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Coronary Artery Disease
Interventions: Dual Source Multidetector CT (DSCT) w/ Adenosine enhancement; Radiation
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Ischemia
Interventions: CT and stress test; Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 5
States / cities: Overland Park, Kansas • New York, New York • Columbus, Ohio + 2 more

Conditions: Breast Cancer
Interventions: computed tomography (CT scan), computed tomography (CT scan); Radiation · Device
Lead sponsor: University of Rochester; Other
Eligibility: 40 Years and older · Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Parkinson's Disease
Interventions: Deep Brain Stimulation, DBS surgery; Device · Procedure
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Atrial Fibrillation
Interventions: Ganglionated Plexi mapping and ablation using Natus Cortical Stimulator and standard ablation catheters; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Coronary Arteriosclerosis
Interventions: Not listed
Lead sponsor: MDDX LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: Albany, New York • Poughkeepsie, New York

Search by objective public record fields.

Positron Emission Tomography-computed Tomography (PET-CT) for Main & Branch Intraductal Papillary Mucinous Neoplasm

Computed Tomographic Coronary Angiography for Acute Chest Pain Evaluation

Cathartic-Free DECT Colonography for Detection of Colonic Polyps

F-18 Sodium Fluoride in Prostate Cancer

Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)

Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma

Closed Sinus Augmentation With a Calcium Phosphosilicate Putty

Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System

Rule Out Myocardial Infarction by Computer Assisted Tomography

Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker

Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques

A Study to Evaluate Safinamide's Effect on Dopamine and Serotonin's Availability by Using Brain Imaging

Low Field and High Field Magnetic Resonance Imaging Assessments on Pediatric Patients

Koning Breast Computed Tomography Guided Neoadjuvant Treatment Monitoring

Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)

Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease

Registration and Fusion of Real-Time Ultrasound With CT for Lesion Localization and Characterization

Radiation Safety Alert

Adenosine Dual Source Computed Tomography (CT) Versus Adenosine Single Photon Emission Computed Tomography (SPECT)

Dual Energy CT for Ischemia Determination Compared to "Gold Standard" Non-Invasive and Invasive Techniques

Role of 3D Tomography in Breast Cancer

Clinical Outcomes of Deep Brain Stimulator (DBS) Electrodes Placed Using Intraoperative Computed Tomography (CT) and Frameless Stereotaxis

Prospective Evaluation of CT Guided Ablation of Cardiac Ganglionated Plexi

Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Undergoing Cardiac Computed Tomography (CT) Scanning